Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.27 | 2e-09 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.34 | 1e-08 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-08 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-08 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-07 |